English-language podcasts

Science Magazine Podcast

GLP-1 targets beyond obesity, and misusing brain data

47 min

Listen through the publisher, then discuss the episode here or arrange an in-person Roundtable. Your city determines where to meet.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

First up on the podcast, people are buying consumer-grade brain wave detectors ostensibly to help with sleep, concentration, and meditation. But as freelance investigative journalist Jonathan Moens (https://jonathan-moens.com/) describes, companies are getting more than the price of the devices in the exchange (https://www.science.org/doi/10.1126/science.zp18ht9)—including training data for artificial intelligence models—in many cases without the consent of the user. Next on the show, we delve into the many uses for glucagonlike peptide-1 (GLP-1) agonist drugs beyond reducing obesity. Host Sarah Crespi talks with one of the special issue editors, Yevgeniya Nusinovich, senior editor at Science, about their potential for everything from improving cognition to combating cancer. Then we hear from Nora Volkow (https://nida.nih.gov/about-nida/directors-page/biography-dr-nora-volkow), director of the National Institute on Drug Abuse at the National Institutes of Health, about hopes for using GLP-1 therapies to address addiction (https://www.science.org/doi/10.1126/science.aej9836) to a range of substances. See the whole special issue here (https://www.science.org/doi/10.1126/science.aen0869). This week’s episode was produced with help from Podigy (https://podigy.co/). Image: Long Wei/VCG via Getty Images

Episode information is provided by the publisher. Listening takes place on the publisher’s service.

Listen at the source ↗

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

More from Science Magazine Podcast

Science Magazine Podcast

Why an early Alzheimer’s theory is making a comeback, the U.S.’s electricity crisis, and improving precision medicine

51 min

First up on the podcast, producer Kevin McLean talks with staff writer Jennie Erin Smith about a new old idea for Alzheimer’s disease. They discuss how the cholinergic hypothesis originally came about, how it fell out of fashion, and why it’s making a comeback now (https://www.science.org/doi/10.1126/science.z91c7ic). Next on the show, the United States can make more power as demand goes up, but moving that increased amount of electricity around the country is proving problematic. Madeline Yozwiak (https://www.madyoz.com/), a postdoctoral scholar in the Engineering and Public Policy Department at Carnegie Mellon University, joins host Sarah Crespi to discuss her Policy Forum article on the barriers to scaling up the country’s electric grid (https://www.science.org/doi/10.1126/science.aeh4460) and some potential solutions. Finally, boosting precision medicine by looking at All of Us (https://www.science.org/doi/10.1126/scitranslmed.adt8040). The National Institutes of Health’s All of Us

Discuss this episode

Community Poll

Landscape restoration needs funding commitments that extend beyond normal political terms.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

Your carry-on fits only if you sit on it. Do you try the airport sizer?

Your suitcase is slightly larger than the airline allows, although it has fit overhead on previous flights. Checking it costs extra and risks missing a connection. Other passengers have equally questionable bags and staff are checking inconsistently.

Does uneven enforcement weaken a traveler's duty to follow the rule?

Explore this quandary